Skip to main content

Table 2 Ingenuity pathways analysis

From: Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor

Diseases and disorders   
Name p-value Molecules
Genetic Disorder 4,26E-09 - 1,42E-02 139
Cancer 2,72E-05 - 1,42E-02 91
Connective Tissue Disorders 4,26E-09 - 1,42E-02 57
Developmental Disorder 2,22E-06 - 1,42E-02 32
Dermatological Diseases and Conditions 3,49E-08 - 1,42E-02 29
Molecular and cellular functions   
Name p-value Molecules
Cellular Growth and Proliferation 5,25E-06 - 1,42E-02 75
Gene Expression 1,28E-08 - 1,42E-02 67
Cellular Development 6,24E-09 - 1,42E-02 63
Cell Cycle 2,80E-06 - 1,42E-02 32
DNA Replication, Recombination, and Repair 2,71E-06 - 1,42E-02 15
  1. List of Ingenuity Networks and Biological Functions from predicted targets of miRNA differentially expressed during EGF treatment.
\